分享您的故事

Colorectal cancer is hard. It’s traumatic. But the fight can also be inspirational. Believe it or not,
sharing what you’ve been through might just be the encouragement someone else needs to face their fight
today. It can help you heal, too.

We encourage anyone with a colorectal cancer story to share. To get ideas of what others said, check
out our Champion Stories Hub.

分享您的故事

Colorectal cancer is hard. It’s traumatic. But the fight can also be inspirational. Believe it or not, sharing what you’ve been through might just be the encouragement someone else needs to face their fight today. It can help you heal, too.

We encourage anyone with a colorectal cancer story to share. To get ideas of what others said, check out our Champion Stories Hub.

您为我们的工作增添动力。 Your gift will give more time to patients and caregivers.

您为我们的工作增添动力。 Your gift will give more time to patients and caregivers.

准备好与我们并肩作战了吗?

在社交媒体上关注 @FightCRC

At Fight CRC, we’re dedicated to advancing health equity and raising awareness about disparities in cancer care.Hispanic/Latino individuals are more likely to be diagnosed with colorectal cancer at a later stage—putting them at higher risk for worse outcomes. We’re working to change that and improve outcomes for all communities.#HealthEquity #NationalMinorityHealthMonth #MinorityHealthMonth #MinorityHealth #ColorectalCancer #ColonCancer
A new study in Nature points to colibactin—a DNA-damaging toxin made by certain E. coli strains as a potential clue to #EOCRC. Colibactin-linked mutations were found to be 3.3 times more common in CRC patients under 40 compared to those over 70.We asked our board member & researcher @c_eng1 about this study. She said this suggests, but does not prove, that E. coli infection may contribute to early-onset CRC. More research is needed & ongoing. Stay tuned.
Genetic testing can provide lifesaving information to patients and their families! While it's commonly believed that genetic testing is only for those with a known family risk, guidelines recommend it for anyone diagnosed with colorectal cancer before age 50. Even those diagnosed after 50 can benefit.In partnership with CGA-IGC, Michelle Springer, a genetic counselor with the University of Colorado Hereditary Cancer Program and a member of CGA-IGC, explains why genetic testing is crucial.
Have you had your #biomarkers tested? Sydney Stoner, diagnosed with stage 4 #coloncancer at age 27, shares how biomarker testing has impacted her treatment options. If you haven't been tested yet, ask your oncologist—it could open up new treatment possibilities for you! 💙